Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Tombrello, Michael Monko

Premium

Arrowhead Research, the parent company of RNAi drugs startup Calando Pharmaceuticals, said that it has named Thomas Tombrello to its scientific advisory board.

Tombrello is chairman of the division of physics, mathematics, and astronomy at the California Institute of Technology. He is also the institute's technology assessment officer, Arrowhead said.


Michael Monko has become vice president of sales for the research products segment of Serologicals. That segment consists of Chemicon International and the Upstate Group.

Monko comes to Serologicals from Invitrogen, where for almost more than 20 years he held a number of sales positions. Most recently, he was the senior director of sales force effectiveness.

He holds an MBA from Babson College in Wellesley, Mass., and a BS in biochemistry from the University of New Hampshire.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.